| Hypertension: reflections on risks and prognostication. | |
| | |
MedLine Citation:
|
PMID: 19427490 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Framingham Heart Study cardiovascular disease prospective population epidemiologic research has played an important role in the evolution of modern cohort study design and the advancement of preventive cardiology. To date no single essential factor has been identified; multiple interrelated factors are promoting increased risk for development of CHD. Elevated blood pressure has emerged as a prominent member of cardiovascular risk factors. The study's documentation of a strong link of blood pressure to development of cardiovascular events stimulated the pharmaceutical industry to develop medications for controlling blood pressure and, in turn, national campaigns to combat hypertension and its adverse vascular outlook. |
| | |
Authors:
|
William B Kannel |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: The Medical clinics of North America Volume: 93 ISSN: 1557-9859 ISO Abbreviation: Med. Clin. North Am. Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-05-11 Completed Date: 2009-06-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 2985236R Medline TA: Med Clin North Am Country: United States |
Other Details:
|
Languages: eng Pagination: 541-58, Table of Contents Citation Subset: AIM; IM |
Affiliation:
|
Boston University School of Medicine/Framingham Heart Study, Framingham, MA 01702-5827, USA. billkannel@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Age Factors Aged Aged, 80 and over Antihypertensive Agents / therapeutic use Cardiovascular Diseases / etiology, physiopathology* Coronary Disease / etiology, physiopathology Female Humans Hypertension / complications, drug therapy, physiopathology* Hypertrophy, Left Ventricular / complications Male Middle Aged Obesity / complications Prognosis Risk Factors |
| Grant Support | |
ID/Acronym/Agency:
|
N01-HC-25195/HC/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Current challenges and unresolved problems in hypertensive disease.
Next Document: New insights into target organ involvement in hypertension.